ADPT- Adaptive Biotechnologies Corporation

Name: Adaptive Biotechnologies Corporation Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Adaptive Biotechnologies Corporation (ADPT) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 23 sells. ADPT is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Robins Chad M	2.18M	$32.03M	-
Other	Robins Harlan S	1.51M	$22.21M	-
Other	Bobulsky Susan	427.8K	$6.28M	-
COO	Rubinstein Julie	396.8K	$5.83M	-259,638
Other	Benzeno Sharon	272.8K	$4.01M	-

Activity

Buys and sells only

Transactions

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 31, 2026	Rubinstein Julie88	President And COO	Sale+OE	57,180	$13.14	$751,302.98	-3.0%	-	-
Mar 26, 2026	Rubinstein Julie88	President And COO	Sale+OE	57,180	$14.03	$802,235.40	-3.9%	-	-
Mar 23, 2026	Rubinstein Julie88	President And COO	Sale+OE	57,180	$13.46	$769,642.80	-3.8%	-	-
Mar 13, 2026	Rubinstein Julie88	President And COO	Sale+OE	179,703	$13.21	$2,374,058.11	-6.5%	-	-
Mar 11, 2026	Piskel Kyle	Chief Financial Officer	Sell	18,672	$13.17	$245,910.24	-6.7%	-	-
Mar 11, 2026	Robins Harlan S85	Chief Scientific Officer	Sell	470,266	$13.17	$6,193,403.22	-12.2%	-	-
Mar 11, 2026	Robins Chad M63	CEO And Chairman	Sell	470,167	$13.17	$6,192,099.39	-8.7%	-	-
Mar 11, 2026	Griffin Michelle Renee81	Director	Sell	15,394	$13.91	$214,130.54	-49.6%	-	-
Mar 11, 2026	Bobulsky Susan	Chief Commercial Officer, Mrd	Sell	41,338	$13.17	$544,421.46	-8.8%	-	-
Mar 11, 2026	Benzeno Sharon79	Chief Commercial Ofc Imm Med	Sell	63,103	$13.17	$831,066.51	-18.8%	-	-

← PrevPage 2Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC